Department of Internal Medicine, Armed Forces Capital Hospital, Seongnam, Korea.
Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
Korean J Intern Med. 2020 Nov;35(6):1457-1467. doi: 10.3904/kjim.2019.292. Epub 2020 Mar 30.
BACKGROUND/AIMS: Detailed nationwide information regarding the recent status and time trends of kidney transplantation (KT) in South Korea is limited.
We performed a nationwide, population-based cohort study using the national claims database of Korea. We included KT recipients from 2008 to 2016, and their demographic and clinical characteristics were collected. The prognostic outcome was graft failure consisted of patient death and death-censored graft failure (DCGF).
We studied 14,601 KT recipients with median follow-up duration of 3.96 years. The median age at the time of transplantation consistently increased from the past, and proportion of underlying diabetes mellitus prominently increased, reaching 35.6% in 2016. The preemptive KT accounted for approximately 30% of the total transplantation cases. The recipients showed a 10-year cumulative graft survival rate of 71.8%, consisting of 10-year DCGF free survival of 77.6% and patient survival of 92.8%. Age ≥ 20 and < 30 years, age ≥ 70 years, underlying history of diabetes, non-preemptive transplantation, and poor compliance on tacrolimus and mycophenolic acid were the significant risk factors associated with worse DCGF outcome. The economic cost of KT showed prominently increasing trends, reaching a total insured fee of > 60,000,000$ in 2016. However, the expansion was mainly burdened by the national insurance service but not by the patients.
In South Korea, the number of kidney transplantation in elderly or in patients with comorbidities has been increasing. Complex clinical factors were associated with medication compliance and patient prognosis.
背景/目的:关于韩国最近肾脏移植(KT)的现状和时间趋势的详细全国性信息有限。
我们使用韩国国家索赔数据库进行了一项全国性的基于人群的队列研究。我们纳入了 2008 年至 2016 年的 KT 受者,并收集了他们的人口统计学和临床特征。预后结果是移植失败,包括患者死亡和死亡校正移植失败(DCGF)。
我们研究了 14601 名 KT 受者,中位随访时间为 3.96 年。移植时的中位年龄持续增加,并且基础糖尿病的比例显著增加,2016 年达到 35.6%。抢先 KT 约占总移植病例的 30%。受者显示 10 年累积移植物存活率为 71.8%,包括 10 年 DCGF 无生存的 77.6%和患者生存的 92.8%。年龄≥20 且<30 岁、年龄≥70 岁、基础糖尿病史、非抢先移植以及他克莫司和吗替麦考酚酸的依从性差是与 DCGF 结果较差相关的显著危险因素。KT 的经济成本呈明显上升趋势,2016 年总保险费用超过 6000 万美元。然而,这种扩张主要是由国家医疗保险服务承担的,而不是由患者承担的。
在韩国,老年或合并症患者的肾脏移植数量不断增加。复杂的临床因素与药物依从性和患者预后相关。